Seattle Genetics | SGEN - O Lucro Antes De Impostos



O Lucro Antes De Impostos Alterar Data
AbbVie USD 4.38B 1.92B 2025-09
Acadia Pharmaceuticals USD 26.32M 18.28M 2025-12
Agios Pharmaceuticals USD -109.06M 5.62M 2025-12
Amgen USD 3.92B 2.35B 2025-09
Astellas Pharma JPY 133.96B 29.77B 2025-12
Bayer EUR -1.16B 735M 2025-09
Biogen USD 557.3M 186.7M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Celldex Therapeutics USD -81.32M 14.27M 2025-12
Daiichi Sankyo JPY 106.73B 48.96B 2025-12
Eisai JPY 22B 7.47B 2025-12
Eli Lilly USD 7.23B 456M 2025-09
Esperion Therapeutics USD 63.67M 95M 2025-12
Exelixis USD 252.69M 275K 2025-12
Genmab DKK 55M 427M 2025-12
Gilead Sciences USD 3.64B 1.21B 2025-09
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Glaxosmithkline GBP 2.46B 569M 2025-09
Incyte USD 389.94M 92.37M 2025-12
Insmed USD -326.93M 41.77M 2025-12
Karyopharm Therapeutics USD -39.9M 9.01M 2025-12
MacroGenics USD -14.93M 31.75M 2025-12
Merck USD 6.74B 22M 2025-09
Moderna USD -187M 631M 2025-09
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Novartis USD 4.64B 445M 2025-12
Pfizer USD 3.33B 290M 2025-09
Puma Biotechnology USD 20.61M 24.76M 2024-09
Regeneron Pharmaceuticals USD 1.76B 244.6M 2025-09
Sanofi EUR -1.16B 5.5B 2025-12
Sarepta Therapeutics USD -407.67M 213.63M 2025-12
Takeda JPY 133.86B 105.69B 2025-12
Teva Pharmaceutical Industries USD 91M 555M 2025-12
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09
Xencor USD -4.27M 1.76M 2025-12